Brief: Yichang Hec Changjiang Pharmaceutical Says Recombinant Human Insulin Injection Got Launch Approval
15/06/2020 14:39
June 15 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co
Ltd 1558.HK :
* RECOMBINANT HUMAN INSULIN INJECTION GETS APPROVAL FOR
LAUNCH
FROM CHINA NMPA
Source text for Eikon: urn:newsml:reuters.com:*:nHKSbgdYzJ
Further company coverage: 1558.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million